Results
3
Companies which are more than 50% undervalued based on analyst price target.
3 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SQURPHARMA New | ৳211.30 | -5.4% | 0.7% | ৳187.3b | ৳322.80 | PE9.3x | E12.8% | 5.2% | ||
RENATA | ৳633.30 | -3.4% | -48.0% | ৳72.6b | ৳1,109.00 | PE22.8x | n/a | 1.5% | ||
BXPHARMA | ৳80.90 | -11.5% | -44.7% | ৳36.1b | ৳177.50 | PE6.1x | E16.5% | 4.9% |